Relationship between self-stigma about alcohol dependence and severity of alcohol drinking and craving.


Journal

BMJ mental health
ISSN: 2755-9734
Titre abrégé: BMJ Ment Health
Pays: England
ID NLM: 9918521385306676

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 31 07 2023
accepted: 17 10 2023
medline: 24 11 2023
pubmed: 23 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

The correlates and consequences of stigma surrounding alcohol use are complex. Alcohol use disorder (AUD) is typically accompanied by self-stigma, due to numerous factors, such as shame, guilt and negative stereotypes. Few studies have empirically examined the possible association between self-stigma and alcohol-related outcomes. To investigate the relationship between self-stigma about alcohol dependence and the severity of alcohol consumption and craving. In a sample of 64 participants, the majority of whom had a diagnosis of AUD (51), bivariate correlations were first conducted between Self-Stigma and Alcohol Dependence Scale (SSAD-Apply subscale) scores and Alcohol Use Disorders Identification Test (AUDIT) scores, Alcohol Timeline Follow-Back, Obsessive-Compulsive Drinking Scale (OCDS) scores and Penn Alcohol Cravings Scale scores. Based on the results, regression analyses were conducted with SSAD scores as the predictor and AUDIT and OCDS scores as the outcomes. SSAD scores positively correlated with AUDIT scores, average drinks per drinking day, number of heavy drinking days and OCDS scores (p<0.001, p=0.014, p=0.011 and p<0.001, respectively). SSAD scores were also found to be a significant predictor of AUDIT and OCDS scores (p<0.001 and p<0.001, respectively), even after controlling for demographics. Higher levels of self-stigma were associated with more severe AUD, greater alcohol consumption, and more obsessive thoughts and compulsive behaviours related to alcohol. Our results suggest that potential interventions to reduce self-stigma may lead to improved quality of life and treatment outcomes for individuals with AUD.

Sections du résumé

BACKGROUND BACKGROUND
The correlates and consequences of stigma surrounding alcohol use are complex. Alcohol use disorder (AUD) is typically accompanied by self-stigma, due to numerous factors, such as shame, guilt and negative stereotypes. Few studies have empirically examined the possible association between self-stigma and alcohol-related outcomes.
OBJECTIVE OBJECTIVE
To investigate the relationship between self-stigma about alcohol dependence and the severity of alcohol consumption and craving.
METHODS METHODS
In a sample of 64 participants, the majority of whom had a diagnosis of AUD (51), bivariate correlations were first conducted between Self-Stigma and Alcohol Dependence Scale (SSAD-Apply subscale) scores and Alcohol Use Disorders Identification Test (AUDIT) scores, Alcohol Timeline Follow-Back, Obsessive-Compulsive Drinking Scale (OCDS) scores and Penn Alcohol Cravings Scale scores. Based on the results, regression analyses were conducted with SSAD scores as the predictor and AUDIT and OCDS scores as the outcomes.
FINDINGS RESULTS
SSAD scores positively correlated with AUDIT scores, average drinks per drinking day, number of heavy drinking days and OCDS scores (p<0.001, p=0.014, p=0.011 and p<0.001, respectively). SSAD scores were also found to be a significant predictor of AUDIT and OCDS scores (p<0.001 and p<0.001, respectively), even after controlling for demographics.
CONCLUSIONS CONCLUSIONS
Higher levels of self-stigma were associated with more severe AUD, greater alcohol consumption, and more obsessive thoughts and compulsive behaviours related to alcohol.
CLINICAL IMPLICATIONS CONCLUSIONS
Our results suggest that potential interventions to reduce self-stigma may lead to improved quality of life and treatment outcomes for individuals with AUD.

Identifiants

pubmed: 37993282
pii: bmjment-2023-300852
doi: 10.1136/bmjment-2023-300852
pmc: PMC10668173
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCATS NIH HHS
ID : UH2 TR000963
Pays : United States
Organisme : NCATS NIH HHS
ID : UH3 TR000963
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Alcohol Clin Exp Res. 2009 Jul;33(7):1145-50
pubmed: 19389200
Drug Alcohol Depend. 2018 Aug 1;189:62-69
pubmed: 29883870
Psychol Med. 2015 Jan;45(1):11-27
pubmed: 24569086
Alcohol Clin Exp Res. 1999 Aug;23(8):1289-95
pubmed: 10470970
Subst Use Misuse. 2019;54(8):1376-1384
pubmed: 30945955
Psychiatr Serv. 2012 Oct;63(10):974-81
pubmed: 22855130
Am Psychol. 2020 Dec;75(9):1300-1311
pubmed: 33382299
Am Psychol. 2004 Oct;59(7):614-625
pubmed: 15491256
Soc Sci Med. 2010 Dec;71(12):2150-61
pubmed: 21051128
Front Neurosci. 2018 May 11;12:303
pubmed: 29867316
Epidemiology. 1990 Jan;1(1):43-6
pubmed: 2081237
Stigma Health. 2020 May;5(2):158-167
pubmed: 33102697
J Addict Behav Ther Rehabil. 2013 May 27;2(2):
pubmed: 25401117
Soc Sci Med. 2014 Feb;103:24-32
pubmed: 24507908
Addiction. 2012 Jan;107(1):39-50
pubmed: 21815959
Ind Psychiatry J. 2022 Jul-Dec;31(2):299-305
pubmed: 36419702
J Addict Nurs. 2020 Oct/Dec;31(4):295-301
pubmed: 33264202
Drug Alcohol Depend. 2011 Mar 1;114(1):12-7
pubmed: 20933344
Addict Behav. 1993 May-Jun;18(3):347-53
pubmed: 8393611
J Health Soc Behav. 1997 Jun;38(2):177-90
pubmed: 9212538
Am J Epidemiol. 2010 Dec 15;172(12):1364-72
pubmed: 21044992
J Stud Alcohol. 2003 Jan;64(1):120-6
pubmed: 12608492
Addiction. 2000 Aug;95 Suppl 2:S211-7
pubmed: 11002915
J Bioeth Inq. 2017 Jun;14(2):275-286
pubmed: 28470503
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Issues Ment Health Nurs. 2023 Mar;44(3):162-175
pubmed: 36725369
Eur Addict Res. 2022;28(6):446-454
pubmed: 36088900
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):186-195
pubmed: 35026172
Alcohol Res. 2020 Aug 20;40(2):05
pubmed: 32832310

Auteurs

Madeline E Crozier (ME)

Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA.

Mehdi Farokhnia (M)

Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA.
Department of Mental Health, Johns Hopkins University, Baltimore, Maryland, USA.

Susan Persky (S)

Social and Behavioral Research Branch, National Human Genome Research Institute Division of Intramural Research, National Institutes of Health, Bethesda, Maryland, USA.

Lorenzo Leggio (L)

Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA.
Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, New England, USA.
Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, USA.

Brenda Curtis (B)

Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA brenda.curtis@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH